Delivery Order SPE2DR25D9239-SPE2DR26FFBK2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The award, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,108.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 133 mg/10 mL vials. This delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, carries no set-aside designation, indicating that DMS Pharmaceutical Group competed successfully in an...
- The Defense Logistics Agency awarded a delivery order valued at $3,730.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. This firm fixed-price delivery order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL (133 mg/10 mL vial). This firm fixed-price delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $26,113.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation, indicating the award was made through competitive procurement. The delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,730.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for EXPAREL 133 mg/10 ml vials. This firm fixed-price delivery order, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, requires no set-aside designation, indicating the awardee competed successfully in unrestricted federal procurement. The product will be...
- The Defense Logistics Agency awarded a $5,021.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for EXPAREL 266 mg/20 ml vials. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the vendor competed in an unrestricted federal procurement environment. This award falls under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $125,531.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. This firm fixed-price delivery order, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, represents a direct procurement with no set-aside designation. The award falls under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency, under its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 1.3% 20ML in a quantity of 10 units. This firm fixed-price delivery order, valued at $7,531.89, was awarded on June 27, 2025, with an ultimate completion date of the same day. The award carries no set-aside designation, allowing DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $15,063.78 with an ultimate completion date of October 9, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBK2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,730.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. This firm fixed-price delivery order, issued on November 7, 2025, is scheduled for ultimate completion by December 2, 2025, and carries no set-aside designation, indicating the award was made through open competition. The order is issued under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains for Department of Defense military healthcare facilities worldwide. EXPAREL is a specialty surgical product utilized for local anesthesia and post-operative pain management, aligning with DMS Pharmaceutical Group's demonstrated capability to supply specialized pharmaceuticals and medical consumables across multiple therapeutic categories. The vendor's performance on this delivery order continues its role as a critical pharmaceutical supplier within the federal military medical system, leveraging its established relationships with DLA's Medical Supply Chain division and its portfolio encompassing branded and generic prescription medications, biologics, vaccines, and specialty surgical products. The contract reinforces DMS Pharmaceutical Group's position as a regional prime vendor contractor under the broader PPV-G GEN V framework, which extends through December 31, 2036.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 11/7/25 |